Madrigal Pharmaceuticals Q3 EPS $(3.79) Down From $(3.75) YoY

Madrigal Pharmaceuticals (NASDAQ:MDGL) reported quarterly losses of $(3.79) per share. This is a 1.07 percent decrease over losses of $(3.75) per share from the same period last year.

Madrigal Pharmaceuticals (NASDAQ:MDGL) reported quarterly losses of $(3.79) per share. This is a 1.07 percent decrease over losses of $(3.75) per share from the same period last year.

Total
0
Shares
Related Posts